A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

Clinical trial NCT06573281 · COMPLETED

Trial details

NCT number: NCT06573281
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2024-09-30
Primary completion: 2026-02-26
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.